ALPMY Stock News 11.5800 05/06/2014 06:03:12 Astellas Pharma

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Astellas Pharma Inc (ALPMY) 11.5800 $ALPMY

Is There Value In Cytokinetics Following Its 60% Drop?
Todd Campbell, The Motley Fool - Motley Fool - Fri Apr 25, 10:50AM CDT
Big money can be made in owning promising pipelines, but only if trial data validates the hope. In the case of Cytokinetics , hope was dashed when the company reported its drug for ALS, also known as Lou Gehrig's Disease, failed to meet its primary...

3 Drugs Johnson & Johnson’s Investors Better Know About
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 24, 5:30PM CDT
Johnson & Johnson's  sales grew 3.5% during the past year, but only because of big sales growth from a handful of its recently launched drugs. Among these fast-growing new drugs are Johnson's next-generation treatment for diabetes, a new...

Medivation Signs Deal with OncoFusion Therapeutics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 5:24PM CDT
Medivation, Inc. (MDVN) entered into a research and license agreement with OncoFusion Therapeutics, Inc

How Big Is the Threat to This Johnson & Johnson Blockbuster?
Todd Campbell, The Motley Fool - Motley Fool - Fri Apr 18, 5:30PM CDT
Johnson & Johnson has been one of the most successful big drug companies over the past three years. Despite an industry-wide sales drag caused by patent expiration on top-selling drugs, Johnson has skirted the headwind thanks to a wave of...

Legal Settlement for Astellas Pharma - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 11:41AM CDT
Astellas Pharma announced that it has reached an agreement with the U.S. DOJ to resolve civil claims regarding the marketing of Mycamine for injection

Tetraphase Slumps: TTPH Falls 10.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 7:49AM CDT
Tetraphase Pharmaceuticals saw a big move last session, as the company’s shares fell by over 10% on the day

AVEO-Biodesix Ink Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 4:00PM CDT
AVEO Pharma entered into an agreement with Biodesix to develop and commercialize ficlatuzumab with VeriStrat.

PharmAthene (PIP) Crumbles: Stock Falls by 7.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 7:51AM CDT
PharmAthene saw a big move last session, as the company’s shares fell by over 7% on the day

Biotech Stock Roundup: MannKind Soars on Panel Vote, Halozyme Plunges on Safety Concerns - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Apr 09, 11:46AM CDT
Last week saw a couple of positive FDA panel votes as well as some disappointing data on experimental drugs.

Why I Bought Exelixis
Sean Williams, The Motley Fool - Motley Fool - Fri Apr 04, 11:05AM CDT
Some days as a biotech investor, no matter how savvy you think you are, you just have to bury your head in the sand because you're bound to experience a bad day. That's what happened last week to shareholders of Exelixis , a company I've been very...

ARIAD Candidate in Phase II Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 5:10PM CDT
ARIAD started phase II pivotal study on AP26113 for non-small cell lung cancer (NSCLC) in patients who had previously been treated with Pfizer's Xalkori (crizotinib).

AstraZeneca's Forxiga Approved in Japan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 25, 3:45PM CDT
AstraZeneca announced that its type II diabetes drug, Forxiga, has been approved by the Japanese Ministry of Health, Labour and Welfare.

Japan Approves Medivation/Astellas' Xtandi - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 25, 12:50PM CDT
Prostate cancer treatment, Xtandi, which is already approved in more than 35 countries is now approved in Japan.

AVEO Regains AV-203 Rights from Biogen - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 5:10PM CDT
AVEO Oncology (AVEO) recently announced that it has regained worldwide rights of candidate AV-203 from Biogen Idec (BIIB).

Medivation, Inc: Fast Growing Drugs That May Become Blockbusters
Todd Campbell, The Motley Fool - Motley Fool - Fri Mar 21, 1:30PM CDT
Blockbuster status -- the gold medal term awarded to therapies racking up sales of more than $1 billion per year -- is the Holy Grail for drug developers. Arguably, it's the chance to discover blockbusters that fuels industry R&D spend and...

Medivation-Astellas Seek Xtandi Label Expansion - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 19, 3:20PM CDT
The companies are looking to get Xtandi approved for the chemo-naive patient population.

AVEO Q4 Loss Narrower than Expected - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 8:10AM CDT
AVEO Pharmaceuticals reported a fourth quarter 2013 loss of 32 cents per share.

Was Medivation's Quarter a Disaster?
Todd Campbell, The Motley Fool - Motley Fool - Mon Mar 03, 5:30PM CST
Medivation's  sell-off last week reflects investor disappointment in guidance for sales of Xtandi, a prostate cancer drug prescribed to patients who fail to respond to chemotherapy. Sales of Xtandi jumped double digit percentages...

Medivation Swings to Earnings in Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 8:30AM CST
Xtandi's approval in the pre-chemo setting would boost sales significantly.

Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Feb 19, 8:27AM CST
The Medicines Co. was also in the news with an FDA advisory panel refusing to back the company's antiplatelet agent, Cangrelor.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Phoenix Reveals Cost-Saving Hacks for Transfer Students

Updated Category News Views 5

Making College Cost Manageable Okay, let's get real about college costs. Tuition fees got folks holding their breath tighter than a bull in a bear market. University of Phoenix ain't turning a blind eye—during National Transfer Student Week, they're shouting from the rooftops about pocket-friendly ways to snag that degree without selling your soul or flipping another...

Continue Reading
Chemours Set to Release Q3 2026 Results This November

Updated Category News Views 3

Mark Your Calendars for Chemours' Upcoming Earnings If you've got a hand in Chemours' pie, circle November 2 on your calendar. That's the day they pull back the curtain on their Q3 2026 financial results. It's an after-market reveal, and if you're hoping to catch the full picture, they've lined up a conference call at 8:00 a.m. EST the very next day, on November 3. Early...

Continue Reading
European Flavors: A Halloween Food Revolution

Updated Category News Views 4

Who would've thought Halloween would toss a spin on fine dining? What's usually known for candy corn and spooky costumes has teamed up with European flavors for a night unlike any other. And we're talking more than just trick-or-treating here, folks. A New Kind of Halloween Spread This year, The Charming Taste of Europe has thrown itself into the Halloween festivities,...

Continue Reading
Mili and Egnyte Transform Financial Advice Delivery

Updated Category News Views 6

AI Powers Up Financial Advisors with New Partnership Ah, the grind never ends for those financial advisors, right? Well, here's a nugget that might just lighten their load. Mili and Egnyte are buddying up to merge AI with secure content platforms, aiming to supercharge how advisors handle client documents. Right off the bat, advisors can crank out personalized advice at a...

Continue Reading
Ellevio Bolsters Stockholm Grid with SEK 1B NIB Loan

Updated Category News Views 6

In a move that packs plenty of juice for Stockholm's energy needs, Ellevio has shaken hands with the Nordic Investment Bank (NIB) in a hefty SEK 1 billion loan agreement. This isn’t just some pocket change—this financing is a ticket to revamping and beefing up the Beckomberga substation, a project hailed for fortifying the regional electricity grid in the Swedish...

Continue Reading
Platform9: Strategic Private Cloud Innovator Emerges

Updated Category News Views 6

Shifting Sands in Private Cloud Infrastructure Here's a nugget for those keeping tabs on infrastructure shifts: Platform9 just got its ticket punched as a Major Player in the latest IDC MarketScape assessment for worldwide private cloud infrastructure software vendors. And if you've been in this game as long as I have, you know this isn't just a bit of puffery—the IDC...

Continue Reading
Husqvarna's Q3 Numbers: A Mixed Bag of Woes and Wins

Updated Category News Views 6

Walking into Husqvarna’s latest interim report, it’s clear they’re facing an uphill struggle. Third quarter numbers can sting when they’re not in line with expectations, and Huskie's feeling the burn with a dip in net sales by 5% organically. Just look at that grimace on their bottom line—their operating income has hit SEK -334 million, a significant drop from...

Continue Reading
Vermiculus Unveils VeriIndex: A Game-Changer for Indices

Updated Category News Views 4

Standing on the Precipice of Index Innovation There’s a seismic shift rumbling through Vermiculus as they roll out their latest brainchild, the VeriIndex. This isn’t just your typical release; it’s the kind of shakeup that slaps you awake like a splash of cold water. Ever since they burst onto the scene in 2020, Vermiculus has been stirring the pot of exchange...

Continue Reading
AI Traffic Sensing By AglaiaSense and Leopard Imaging

Updated Category News Views 9

Revolutionizing Traffic Sensing with Privacy The buzz in Barcelona this November is all about AglaiaSense and Leopard Imaging teaming up at the Smart City Expo World Congress. They're not just hitting exhibit after exhibit. These two are set to roll out their cutting-edge AI traffic sensing tech, and from what I'm hearing, it's miles ahead of anything we've seen before....

Continue Reading
KingClean's New Tech at Canton Fair Ignites Interest

Updated Category News Views 9

KingClean Stirs the Pots at Canton Fair Stretching over the bustling floors of the 140th Canton Fair, KingClean has rolled out its latest innovations in the smart home appliance arena. Now, this isn't just another day at the market—KingClean's pushing the envelope on how household gear should perform and connect globally. Diving Into KingClean's Smart Arsenal At the...

Continue Reading

Top 5 Most Recently Viewed Articles

Cardano Experiences Significant Price Drop Amid Market Trends

Updated Category News Views 178

Cardano Faces a Significant Price Drop Recently, Cardano's price has fallen by 3.95% over just 24 hours, bringing it down to $0.33. This decline is part of a larger trend seen over the past week, with the cryptocurrency dropping by 4.0% from its previous price of $0.34. Analyzing Market Behavior The latest price dip highlights the ongoing volatility within Cardano's...

Continue Reading
Innofactor's Recent Managerial Transactions and Insights

Updated Category News Views 116

Overview of Recent Managerial Transactions at Innofactor Plc On a notable day in November, a series of transactions took place at Innofactor Plc, highlighting the ongoing engagement of its managerial team. The transactions were officially recorded on November 11, closely monitored by interested parties within the Finnish market. Key Individuals Involved Innofactor Plc's...

Continue Reading
CBH Homes Initiates Construction of Innovative New HQ

Updated Category News Views 781

CBH Homes Begins Building Its New Headquarters CBH Homes has recently celebrated a significant milestone with the groundbreaking of their new headquarters, affectionately dubbed "The CBH Starship." This exciting development symbolizes the company's dedication to expanding its operations and enhancing efficiency. Situated in Caldwell, Idaho, this impressive...

Continue Reading
Arverne Group Welcomes Manoelle Lepoutre-Saint-M'leux to Board

Updated Category News Views 151

Arverne Group Welcomes New Board Member Arverne Group, a pioneering industrial organization focused on renewable underground resources, is excited to share the news of Manoelle Lepoutre-Saint-M'leux joining its Board of Directors. Her appointment is pivotal as it demonstrates Arverne Group's commitment to strengthening board governance with proven leaders in the industry....

Continue Reading
Empowering Girls through Education: A New Initiative is Born

Updated Category News Views 451

Empowering Girls through Education: A New Initiative is Born Education Cannot Wait (ECW), a prominent global fund focused on education in emergencies, has launched two groundbreaking grants, totaling $1.9 million. Partnering with organizations such as the United Nations Girls' Education Initiative (UNGEI) and Plan International Canada, these grants aim to transform gender...

Continue Reading